Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
16-Mar-2012 -
In preclinical studies, researchers at SRI International and Astraea Therapeutics have recently evaluated the role of a new drug receptor target that shows promise for the treatment of drug addiction.This potential new drug target belongs to a class of receptors called the nicotinic acetylcholine ...
drug abuse
drug addiction